InMed Pharmaceuticals Inc (INM): ADO Muhammad Consultant & CMO Compa...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

InMed Pharmaceuticals Inc (INM)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	185
Posts	2462
Boards Moderated	0
Alias Born	02/10/2017

Re: None

Thursday, 03/14/2019 6:21:36 PM

Thursday, March 14, 2019 6:21:36 PM

ADO Muhammad

Consultant & CMO
Company NameInMed Pharmaceuticals
Dates EmployedMar 2015 – Present
Employment Duration4 yrs 1 mo
Spearheading the direction of clinical development

Pharmacovigilance and Regulatory Consultant
Company NameNational Agency for Foods and Drugs Administration and Control, Nigeria
Dates EmployedJun 2013 – Nov 2015
Employment Duration2 yrs 6 months
Offering technical support in pharmacovigilance operations and clinical research

Pharmedas Clinical Research & Consultancy
Principal Consultant
Company Name Pharmedas Clinical Research & Consultancy
Dates EmployedDec 2011 – Nov 2015
Employment Duration4 yrs
LocationAbuja (Nigeria), London (UK), Dubai (UAE), Wilmington, Delaware (USA)
Consulting in pharmacovigilance and Clinical Development

Associate Medical Director
Company Name GW Pharmaceuticals
Dates EmployedNov 2006 – Dec 2011
Employment Duration5 yrs 2 mos
Clinical research, pharmacovigilance and medical information.
GWPH market cap is 5.1 Billion dollars

IMLFF

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent INM News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:23 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 08:27:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:38:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 07:58:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 10:05:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 05:34:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 07:33:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 07:12:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:08:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:07:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:07:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:05:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:04:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:04:18 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:21:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 02:02:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 07:50:14 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:29 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/13/2023 10:05:08 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/08/2023 10:05:26 PM

More INM News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow